241 related articles for article (PubMed ID: 16952921)
21. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
Elstein D; Nir A; Klutstein M; Rudensky B; Zimran A
Blood Cells Mol Dis; 2005; 34(3):201-5. PubMed ID: 15885602
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.
Mikkelsen KV; Bie P; Møller JE; Ryde H; Videbaek L; Haghfelt T
Scand J Clin Lab Invest; 2005; 65(8):633-47. PubMed ID: 16319038
[TBL] [Abstract][Full Text] [Related]
23. Utility of N terminal pro brain natriuretic peptide in elderly patients.
Sivakumar R; Wellsted D; Parker K; Lynch M; Ghosh P; Khan SA
Postgrad Med J; 2006 Mar; 82(965):220-3. PubMed ID: 16517806
[TBL] [Abstract][Full Text] [Related]
24. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
25. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
Weber M; Dill T; Arnold R; Rau M; Ekinci O; Müller KD; Berkovitsch A; Mitrovic V; Hamm C
Am Heart J; 2004 Oct; 148(4):612-20. PubMed ID: 15459591
[TBL] [Abstract][Full Text] [Related]
26. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
[TBL] [Abstract][Full Text] [Related]
27. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.
Andersen NH; Poulsen SH; Knudsen ST; Heickendorff L; Mogensen CE
Diabet Med; 2005 Feb; 22(2):188-95. PubMed ID: 15660737
[TBL] [Abstract][Full Text] [Related]
28. Effect of anemia on plasma concentrations of NT-proBNP.
Willis MS; Lee ES; Grenache DG
Clin Chim Acta; 2005 Aug; 358(1-2):175-81. PubMed ID: 15878465
[TBL] [Abstract][Full Text] [Related]
29. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
[TBL] [Abstract][Full Text] [Related]
30. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
Shang YP; Lai L; Chen J; Zhang F; Wang X
J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
[TBL] [Abstract][Full Text] [Related]
31. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.
Baggish AL; Siebert U; Lainchbury JG; Cameron R; Anwaruddin S; Chen A; Krauser DG; Tung R; Brown DF; Richards AM; Januzzi JL
Am Heart J; 2006 Jan; 151(1):48-54. PubMed ID: 16368291
[TBL] [Abstract][Full Text] [Related]
32. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
33. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428
[TBL] [Abstract][Full Text] [Related]
34. Serum N-terminal pro-brain natriuretic peptide in normal Thai subjects.
Leowattana W; Sirithunyanont C; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Kangkagate C; Mahanonda N; Bhuripanyo K
J Med Assoc Thai; 2003 May; 86 Suppl 1():S46-51. PubMed ID: 12866768
[TBL] [Abstract][Full Text] [Related]
35. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
[TBL] [Abstract][Full Text] [Related]
36. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.
Wazni OM; Martin DO; Marrouche NF; Latif AA; Ziada K; Shaaraoui M; Almahameed S; Schweikert RA; Saliba WI; Gillinov AM; Tang WH; Mills RM; Francis GS; Young JB; Natale A
Circulation; 2004 Jul; 110(2):124-7. PubMed ID: 15210589
[TBL] [Abstract][Full Text] [Related]
37. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
[TBL] [Abstract][Full Text] [Related]
38. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
[TBL] [Abstract][Full Text] [Related]
39. Plasma surfactant protein-B: a novel biomarker in chronic heart failure.
De Pasquale CG; Arnolda LF; Doyle IR; Aylward PE; Chew DP; Bersten AD
Circulation; 2004 Aug; 110(9):1091-6. PubMed ID: 15302797
[TBL] [Abstract][Full Text] [Related]
40. NT-proBNP in the differential diagnosis of acute dyspnea in the emergency department.
Zaninotto M; Mion M; Altinier S; Pastorello M; Rocco S; Tosato F; Iliceto S; Plebani M
Clin Biochem; 2005 Nov; 38(11):1041-4. PubMed ID: 16143322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
